Related Experiment Videos
The ampicillin rash as a diagnostic and management problem: case reports and literature review
Abstract:
Ampicillin is the most commonly prescribed antibiotic in the United States, and causes skin reactions in five to ten percent of patient populations. These reactions are considerably more frequent in patients with a viral illness, infectious mononucleosis, and lymphocytic leukemia. Skin reactions to ampicillin are usually of two types: a maculopapular rash in about two thirds of cases, and urticaria in about one third of cases. There is strong evidence that the maculopapular rash is a benign, nonallergic phenomenon. Patients with the maculopapular ampicillin rash are often incorrectly labeled as allergic to ampicillin/penicillin. Ampicillin can be continued and administered again in the future in these patients, and this kind of skin reaction resolves spontaneously in a few days without sequelae. Skin tests are neither required nor recommended to document the nonallergic basis of the maculopapular ampicillin rash.
Insights
Ampicillin-induced maculopapular rash is common but usually benign and nonallergic. Patients experiencing this reaction can often safely receive ampicillin again in the future.
Area of Science:
- Pharmacology
- Dermatology
- Clinical Medicine
Background:
- Ampicillin is a widely prescribed antibiotic in the U.S.
- Skin reactions occur in 5-10% of patients, more frequently in those with viral illnesses or certain leukemias.
- Two main types of reactions exist: maculopapular rash (2/3) and urticaria (1/3).
Purpose of the Study:
- To clarify the nature of ampicillin-induced skin reactions.
- To differentiate between allergic and nonallergic ampicillin rashes.
- To guide clinical management of patients with ampicillin-associated rashes.
Main Methods:
- Review of clinical evidence regarding ampicillin skin reactions.
- Analysis of the characteristics of maculopapular rash versus urticaria.
- Evaluation of the implications for patient labeling and future antibiotic use.
Main Results:
- Strong evidence suggests the maculopapular rash is a benign, nonallergic phenomenon.
- Patients with this rash are frequently mislabeled as penicillin-allergic.
- The maculopapular rash resolves spontaneously without lasting effects.
Conclusions:
- The maculopapular ampicillin rash is not indicative of a true allergy.
- Mislabeling patients as allergic can lead to unnecessary avoidance of essential antibiotics.
- Skin testing is not recommended for diagnosing the nonallergic maculopapular ampicillin rash.